Back to our people page Back to Locations Back to Back to Article

Dhiraj Joshi

Partner

Saudi Arabia, United Arab Emirates

18 years of advising Governments, Senior Leaders, and Decision Makers in the area of Strategy, Transformation, Operational Excellence, and Value Creation

Areas of Focus

Education

ISB
MBA
MICA
Post Graduate in Communications
IMS
Bachelor in Hospital Administration

Past Experience

PwC
Partner

Dhiraj is a Partner based in our Dubai office, overseeing Middle East, South East Asia, and India. He is a member of the Middle East Partner Group and Co-Leader of our Healthcare and Lifesciences Practice.

Dhiraj has special focus on Healthcare, and has deep expertise in: 

  • Corporate Strategy and Strategic Planning/Implementation
  • Corporate Governance and Structuring
  • Investment Strategy, Funding Strategy, and Private Equity
  • Value Creation and Operational Excellence

Prior to joining Arthur D. Little, Dhiraj led the Deals Healthcare Strategy Business for PwC in the Middle East from nine years as Director and then Partner, and advised clients across multiple geographies (over 17 countries) on critical cases.  

In addition to management consulting, Dhiraj mentors new ventures and has been directly involved in three early stage businesses in ME, US, and India.  
 
Dhiraj holds MBA from the Indian School of Business, where he was awarded a Scholarship during the program – one of only two recipients; he is also a Post Graduate (Masters) in Communications , and has a Graduate degree in Hospital Administration.  
 

Healthcare & Life Sciences
COVID-19 – FOCUSING ATTENTION ON THE NEXT TRANSFORMATION IN HEALTHCARE
Dr. Franziska Thomas, Dr. Ulrica Sehlstedt, Ben van der Schaaf, Dhiraj Joshi, Trung Ghi
Essentially the pandemic has shown the strengths and weaknesses of the global healthcare sector – and the opportunities that exist for improvement and transformation. While demonstrating what can be achieved through global collaboration, COVID-19 has also shone a harsh light on the disparities in healthcare access between developed and developing countries.
Find out more
Healthcare & Life Sciences
Building the next generation of emergency care systems
Vikas Kharbanda, Dhiraj Joshi, Samir Imran
Find out more
Healthcare & Life Sciences
Managing competition, price and access
Craig Wylie, Vikas Kharbanda, Dhiraj Joshi
High medicine prices impose a burden on national healthcare systems, where pharmaceuticals account for a significant share of spending, especially for countries in the early stages of maturity in the pharma sector. Competition authorities have expressed concerns that access to affordable, innovative drugs may be at risk due to high prices, market withdrawals or other business strategies, along with national governments’ limited bargaining power against pharma companies.
Find out more

Dhiraj is a Partner based in our Dubai office, overseeing Middle East, South East Asia, and India. He is a member of the Middle East Partner Group and Co-Leader of our Healthcare and Lifesciences Practice.

Dhiraj has special focus on Healthcare, and has deep expertise in: 

  • Corporate Strategy and Strategic Planning/Implementation
  • Corporate Governance and Structuring
  • Investment Strategy, Funding Strategy, and Private Equity
  • Value Creation and Operational Excellence

Prior to joining Arthur D. Little, Dhiraj led the Deals Healthcare Strategy Business for PwC in the Middle East from nine years as Director and then Partner, and advised clients across multiple geographies (over 17 countries) on critical cases.  

In addition to management consulting, Dhiraj mentors new ventures and has been directly involved in three early stage businesses in ME, US, and India.  
 
Dhiraj holds MBA from the Indian School of Business, where he was awarded a Scholarship during the program – one of only two recipients; he is also a Post Graduate (Masters) in Communications , and has a Graduate degree in Hospital Administration.  
 

Healthcare & Life Sciences
COVID-19 – FOCUSING ATTENTION ON THE NEXT TRANSFORMATION IN HEALTHCARE
Dr. Franziska Thomas, Dr. Ulrica Sehlstedt, Ben van der Schaaf, Dhiraj Joshi, Trung Ghi
Essentially the pandemic has shown the strengths and weaknesses of the global healthcare sector – and the opportunities that exist for improvement and transformation. While demonstrating what can be achieved through global collaboration, COVID-19 has also shone a harsh light on the disparities in healthcare access between developed and developing countries.
Find out more
Healthcare & Life Sciences
Building the next generation of emergency care systems
Vikas Kharbanda, Dhiraj Joshi, Samir Imran
Find out more
Healthcare & Life Sciences
Managing competition, price and access
Craig Wylie, Vikas Kharbanda, Dhiraj Joshi
High medicine prices impose a burden on national healthcare systems, where pharmaceuticals account for a significant share of spending, especially for countries in the early stages of maturity in the pharma sector. Competition authorities have expressed concerns that access to affordable, innovative drugs may be at risk due to high prices, market withdrawals or other business strategies, along with national governments’ limited bargaining power against pharma companies.
Find out more

More About Dhiraj
  • ISB
    MBA
  • MICA
    Post Graduate in Communications
  • IMS
    Bachelor in Hospital Administration
  • PwC
    Partner